LESCOL XL 80 Base Milligrams Tablet Prolonged Release

País: Irlanda

Idioma: inglés

Fuente: HPRA (Health Products Regulatory Authority)

Ingredientes activos:

FLUVASTATIN

Disponible desde:

Novartis Pharmaceuticals UK Ltd

Código ATC:

C10AA04

Designación común internacional (DCI):

FLUVASTATIN

Dosis:

80 Base Milligrams

formulario farmacéutico:

Tablet Prolonged Release

tipo de receta:

Product subject to prescription which may be renewed (B)

Área terapéutica:

HMG CoA reductase inhibitors

Estado de Autorización:

Authorised

Fecha de autorización:

2002-01-23

Información para el usuario

PACKAGE LEAFLET: INFORMATION FOR THE USER
LESCOL XL 80 MG PROLONGED-RELEASE TABLETS
Fluvastatin
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IM-
PORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Lescol XL is and what it is used for
2.
What you need to know before you take Lescol XL
3.
How to take Lescol XL
4.
Possible side effects
5.
How to store Lescol XL
6.
Contents of the pack and other information
1. WHAT LESCOL XL IS AND WHAT IT IS USED FOR
Lescol XL contains the active substance fluvastatin sodium which
belongs to a group of medicines
known as statins, which are lipid-lowering medicines: they lower the
fat (lipids) in your blood. They
are used in patients whose conditions cannot be controlled by diet and
exercise alone.
-
Lescol XL is a medicine used to TREAT RAISED LEVELS OF FATS IN THE
BLOOD IN ADULTS, in particu-
lar total cholesterol and so called “bad” or LDL cholesterol,
which is associated with an in-
creased risk of heart disease and stroke.
- in adult patients with high blood levels of cholesterol
- in adult patients with high blood levels of both cholesterol and
triglycerides (another sort of
blood lipid)
-
Your doctor can also prescribe Lescol XL to prevent further serious
cardiac events (e.g. heart
attack) in patients who have already had a heart catheterisation, with
an intervention in the
heart vessel.
If you have any questions about how Lescol XL works or why this
medicine has been prescribed for
you, ask your doctor.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE LESCOL XL
Follow all your doctor’s instructions carefully,

Ficha técnica

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Lescol XL 80 mg Prolonged-release tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Active substance: fluvastatin (as fluvastatin sodium)
Each prolonged-release tablet contains 84.24 mg of fluvastatin sodium
equivalent to 80 mg
fluvastatin free acid.
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Prolonged-release tablets
Yellow, round, slightly biconvex film-coated tablets with bevelled
edges, approx. 10 mm in diameter, debossed with
“LE” on one side and “NVR” on the other side.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Dyslipidaemia
Treatment of adults with primary hypercholesterolaemia or mixed
dyslipidaemia, as an adjunct to diet, when response
to diet and other non-pharmacological treatments (e.g. exercise,
weight reduction) is inadequate.
Secondary prevention in coronary heart disease
Secondary prevention of major adverse cardiac events in adults with
coronary heart disease after percutaneous coronary
interventions (see section 5.1).
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Adults_
Dyslipidaemia
Prior to initiating treatment with Lescol XL, patients should be
placed on a standard cholesterol-lowering diet, which
should be continued during treatment.
Starting and maintenance doses should be individualized according to
the baseline LDL-C levels and the treatment goal
to be accomplished.
The recommended dosing range is 20 to 80 mg/day. For patients
requiring LDL-C reduction to a goal of < 25% a
starting dose of 20 mg fluvastatin may be used in the evening. For
patients requiring LDL-C reduction to a goal of
25%, the recommended starting dose is 40 mg fluvastatin in the
evening. The dose may be uptitrated to 80 mg daily,
administered as a single dose (one Lescol XL 80 mg prolonged release
tablet) at any time of the day or as one 40 mg
dose of
fluvastatin given twice daily (one dose in the morning and one dose in
the evening).
The maximum lipid-lowering effect with a given dose is achieved wit